Please check your internet connection and try again.
## Ecospirin (Aspirin Enteric-Coated)
### Overview
Ecospirin is an enteric-coated formulation of aspirin, an NSAID with antiplatelet, analgesic, antipyretic, and anti-inflammatory properties. The enteric coating delays dissolution until the drug reaches the small intestine, potentially reducing gastric irritation.
### Primary Indications
* **Cardiovascular Protection:** Primary and secondary prevention of cardiovascular events (e.g., myocardial infarction, stroke) in patients at risk.
* **Analgesia/Antipyresis:** Mild to moderate pain and fever. (Note: Less commonly used for these indications compared to other NSAIDs due to its antiplatelet effects and risk of Reye's syndrome in children).
### Adult Dosing
* **Cardiovascular Protection:**
* **Primary Prevention:** Dosing varies widely based on individual risk assessment. Common doses range from **75 mg to 162 mg once daily**. Higher doses are generally not more effective and increase bleeding risk.
* **Secondary Prevention:** Doses typically range from **75 mg to 325 mg once daily**. A loading dose of 160 mg to 325 mg may be used initially in acute coronary syndromes, followed by a maintenance dose.
* **Analgesia/Antipyresis:** Doses typically range from **325 mg to 650 mg every 4 to 6 hours as needed**. Maximum daily dose is generally **4000 mg**.
### Pediatric Dosing
* **Aspirin is generally NOT recommended in children and adolescents (<19 years) for fever or pain due to the risk of Reye's syndrome.**
* **Specific indications (e.g., Kawasaki disease, rheumatologic conditions) require specialized pediatric expert consultation and dosing protocols.**
### Dose Adjustments
* **Renal Impairment:** Use with caution. Dose reduction may be considered in severe renal impairment.
* **Hepatic Impairment:** Use with caution. Dose reduction may be considered in severe hepatic impairment.
### Contraindications
* Hypersensitivity to aspirin, salicylates, NSAIDs, or any component of the formulation.
* History of asthma, urticaria, or other allergic-type reactions precipitated by aspirin or other NSAIDs.
* Active peptic ulceration or gastrointestinal bleeding.
* Children and adolescents with viral infections (e.g., influenza, chickenpox) due to risk of Reye's syndrome.
* Certain bleeding disorders.
### Adverse Effects
* **Gastrointestinal:** Dyspepsia, heartburn, nausea, abdominal pain, GI bleeding, ulceration.
* **Hematologic:** Increased bleeding tendency, bruising, epistaxis.
* **Hypersensitivity:** Bronchospasm, urticaria, angioedema.
* **Other:** Tinnitus, hearing loss (especially at higher doses), dizziness.
### Key Drug Interactions
* **Anticoagulants (e.g., warfarin, heparin, DOACs):** Increased risk of bleeding.
* **Other NSAIDs and COX-2 Inhibitors:** Increased risk of GI toxicity and bleeding.
* **Corticosteroids:** Increased risk of GI ulceration and bleeding.
* **Antihypertensives:** May reduce efficacy of some antihypertensives.
* **Methotrexate:** Increased methotrexate toxicity.
* **Sulfonylureas and Uricosuric Agents:** May enhance effects.
* **Alcohol:** Increased risk of GI bleeding.
### Monitoring
* **Bleeding:** Monitor for signs and symptoms of bleeding (e.g., hematemesis, melena, bruising, prolonged bleeding from cuts).
* **GI Symptoms:** Assess for dyspepsia, abdominal pain.
* **Renal and Hepatic Function:** Consider monitoring in patients with pre-existing impairment or those on long-term therapy.
* **Tinnitus/Hearing:** Monitor for signs of salicylism, especially at higher doses.
### Clinical Pearls
* The enteric coating is intended to protect the stomach but does not eliminate the risk of GI bleeding or ulceration, especially with long-term use or higher doses.
* Do not crush, chew, or break enteric-coated tablets; they must be swallowed whole.
* For acute cardiovascular events, immediate-release aspirin (if available and appropriate) may be preferred for faster absorption and loading dose administration.
* The decision to use aspirin for primary cardiovascular prevention should be individualized, balancing bleeding risk against potential cardiovascular benefit.
***
**Disclaimer:** This information is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional and refer to the most current prescribing information for definitive guidance.
